Trials / Completed
CompletedNCT03947554
Ginseng HRG80 in Stress and Fatigue
Study of the Efficacy of Panax Ginseng Herbal Preparation HRG80 for Prevention and Mitigation of the Symptoms of Stress in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- EuroPharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effects of a specific herbal preparation of Panax ginseng in preventing symptoms of stress in healthy individuals.
Detailed description
HRG80 is an herbal preparation of Panax ginseng with a higher concentration of bioavailable ginsenosides than typical Korean ginseng. This study will test whether HRG80 is effective at preventing symptoms of stress, such as fatigue, impaired memory, difficulty in concentration, attention deficit, restlessness, and irritation related to daily work situations of healthy individuals in comparison to placebo and a standard Pananx ginseng with a lower concentration of ginsenosides.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HRG80 Panax ginseng | Panax ginseng containing 63.4 mg ginsenosides |
| DIETARY_SUPPLEMENT | Panax ginseng | Panax ginseng containing 19.6 mg ginsenosides |
| DIETARY_SUPPLEMENT | Placebo | 800 mg excipient |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-06-15
- Completion
- 2019-07-01
- First posted
- 2019-05-13
- Last updated
- 2019-07-05
Locations
1 site across 1 country: Armenia
Source: ClinicalTrials.gov record NCT03947554. Inclusion in this directory is not an endorsement.